As a responsible and future-oriented company, sustainability is of crucial importance to us. It is therefore one of our strategic pillars. We are currently further developing our company-wide sustainability program. Our goal is to become carbon-neutral by 2030.
At our production site in Solothurn, two big silos have been installed in the beginning for October 2020. In these two giants, we store plastic granules. Before the installation of these silos, granules were delivered and stored on pallets. The silos have been installed for strategic reasons.
Promising start-up opts for Ypsomed's user-friendly autoinjector to treat PMDD
Asarina Pharma has decided to go with our user-friendly two-step autoinjector YpsoMate for its commercial launch of its drug Sepranolone. Sepranolone is the world’s first treatment for pre-menstrual dysphoric disorder (PMDD).
Ultra-modern production plant for injection and infusion systems has started well
At the end of August, we ceremoniously opened our new state-of-the-art production plant in Schwerin, in North-East Germany. The production got off to a good start. Today, three months later, a perfectly tuned team is at work.